The content is available as a PDF (94.3 KB).
Bibliografía
- 1.Villar Álvarez F., Maiques Galán A., Brotons Cuixart C., Torcal Laguna J., Lorenzo Piqueras J., Vilaseca Canals J. Prevención cardiovascularen atención primaria. Aten Primaria. 2001;28:13–27. [Google Scholar]
- 2.Grundy S.M., Pasternak R., Greenland P., Smith S., Fuster V. Assessment of cardiovascular risk by use multiple-risk-factor assessment equations A statement for health care professionals from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 1999;34:1348–1359. doi: 10.1016/s0735-1097(99)00387-3. [DOI] [PubMed] [Google Scholar]
- 3.Anderson K.M., Odell P.M., Wilson P.W.F., Kannel W.B. Cardiovascular disease risk profiles. Am Heart J. 1990;121:293–298. doi: 10.1016/0002-8703(91)90861-b. [DOI] [PubMed] [Google Scholar]
- 4.Marrugat J., Solanas P., D'Agostino R., Sullivan L., Ordovas J., Cordón F. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253–261. doi: 10.1016/s0300-8932(03)76861-4. [DOI] [PubMed] [Google Scholar]
- 5.Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003. doi: 10.1016/s0195-668x(03)00114-3. [DOI] [PubMed] [Google Scholar]
- 6.Anderson K.M., Wilson P.W.F., Odell P.M., Kannel W.B. Un update coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
- 7.Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998;97:1837–1847. doi: 10.1161/01.cir.97.18.1837. [DOI] [PubMed] [Google Scholar]
- 8.Grupo de Estudio de la Diabetes en la Atención Primaria de Salud (GedapS) Guía para el tratamiento de la diabetes tipo 2 en la atención primaria. Harcourt; Madrid: 2000. [Google Scholar]
- 9.Wood D., De Backe G., Faegerman O., Graham I., Mancia G., Pyörala K. Prevention of coronary heart disease in clinical practice.Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434–1503. doi: 10.1053/euhj.1998.1243. [DOI] [PubMed] [Google Scholar]
- 10.Ministerio de Sanidad y Consumo . Control de la hipercolesterolemia en España, 2000. Un instrumento para la prevención cardiovascular. Secretaría General Técnica del Ministerio de Sanidad y Consumo; Madrid: 2000. [Google Scholar]
- 11.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of TheThird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) Jama. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
- 12.World Health Organization International Society of Hypertension 1999 WHO-ISH Guidelines for the management of hypertension. J Hypertens. 1999;17:151–183. [PubMed] [Google Scholar]
- 13.De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601–1610. doi: 10.1016/s0195-668x(03)00347-6. [DOI] [PubMed] [Google Scholar]
- 14.Grundy S.M. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation. 1999;100:988. doi: 10.1161/01.cir.100.9.988. [DOI] [PubMed] [Google Scholar]
- 15.Sersa; Madrid: 1996. (Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular). [Google Scholar]
- 16.D'Agostino S.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham Coronary Heart Disease Prediction Scores: Results of a Multiple Ethnic Groups Investigation. J Am Med Assoc. 2001;286:180–187. doi: 10.1001/jama.286.2.180. [DOI] [PubMed] [Google Scholar]
- 17.Marrugat J., Fiol M., Sala J., Tormo M.J., Segura A. Variabilidad geográfica en España en las tasas de incidencia y mortali dad poblacionales por infarto agudo de miocardio en el estudio IBE. RICA Gac Sanit. 2000;14(Supl 2):81. [Google Scholar]
- 18.Pyörälä K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice Recommendations of the Task Force of the European Society of Cardiology, European. Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;15:1300–1331. doi: 10.1093/oxfordjournals.eurheartj.a060388. [DOI] [PubMed] [Google Scholar]
- 19.Britis Cardiac Society British Hyperlipidaemia Association British Hypertensión Society, endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart. 1998;80:S1–S29. [PMC free article] [PubMed] [Google Scholar]
- 20.Jakson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. Bmj. 2000;320:709–710. doi: 10.1136/bmj.320.7236.709. [DOI] [PMC free article] [PubMed] [Google Scholar]